Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits
-
- Saito Yoshiro
- Systems Life Sciences Laboratory, Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University
-
- Misu Hirofumi
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences PRESTO, Japan Science and Technology Agency
-
- Takayama Hiroaki
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Takashima Shin-ichiro
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Usui Soichiro
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Takamura Masayuki
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Kaneko Shuichi
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Takamura Toshinari
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences
-
- Noguchi Noriko
- Systems Life Sciences Laboratory, Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University
この論文をさがす
抄録
<p>Selenoprotein P (SeP) is a selenium (Se)-rich extracellular protein. SeP is identified as a hepatokine, causing insulin resistance in type 2 diabetes. Thus, the measurement of SeP in serum has received much attention, and several enzyme-linked immunosorbent assay (ELISA) kits for SeP determination are now commercially available. In the present study, we determined the serum SeP levels by our original ELISA and sol particle homogeneous immunoassay (SPIA) methods and also by commercially available kits, and these determinants were compared. We found a kit-dependent correlation of the determinants with our methods. These results suggest that the selection of kit is critical for comparison with our previous reports and for discussing the relationship between the serum SeP levels and disease condition.</p>
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 41 (5), 828-832, 2018-05-01
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204631265664
-
- NII論文ID
- 130006730702
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 028958859
-
- PubMed
- 29709922
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可